Belpointe Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-400	Closed	-$14.9K	–	2388
2023 Q1	$14.9K	Hold	400	–	–	﹤0.01%	2480
2022 Q4	$14K	Buy	+400	New	+$14K	﹤0.01%	2437